Business Description
Mangalam Drugs & Organics Ltd
ISIN : INE584F01014
Total Employee Number:
480Compare
Compare
Traded in other countries / regions
532637.India IPO Date
2005-05-23Description
Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.02 | |||||
Debt-to-EBITDA | -7.46 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.37 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.1 | |||||
3-Year Book Growth Rate | -12.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 25.73 | |||||
9-Day RSI | 33.81 | |||||
14-Day RSI | 38.84 | |||||
3-1 Month Momentum % | -4.43 | |||||
6-1 Month Momentum % | -6.86 | |||||
12-1 Month Momentum % | -66.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.79 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 275.1 | |||||
Days Sales Outstanding | 50.52 | |||||
Days Payable | 180.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -23.56 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.7 | |||||
Operating Margin % | -14.04 | |||||
Net Margin % | -19.13 | |||||
EBITDA Margin % | -6.09 | |||||
FCF Margin % | -3.33 | |||||
OCF Margin % | 1.8 | |||||
ROE % | -35.09 | |||||
ROA % | -13.35 | |||||
ROIC % | -10.95 | |||||
3-Year ROIIC % | -188.77 | |||||
ROC (Joel Greenblatt) % | -16.45 | |||||
ROCE % | -22 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 5.82 | |||||
PS Ratio | 0.19 | |||||
PB Ratio | 0.44 | |||||
Price-to-Tangible-Book | 0.64 | |||||
Price-to-Operating-Cash-Flow | 10.76 | |||||
EV-to-EBIT | -4.53 | |||||
EV-to-EBITDA | -10.36 | |||||
EV-to-Revenue | 0.63 | |||||
EV-to-FCF | -18.98 | |||||
Price-to-GF-Value | 0.44 | |||||
Price-to-Projected-FCF | 0.34 | |||||
Price-to-Median-PS-Value | 0.4 | |||||
Earnings Yield (Greenblatt) % | -22.08 | |||||
FCF Yield % | -17.18 | |||||
Forward Rate of Return (Yacktman) % | 10.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mangalam Drugs & Organics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 2,321.327 | ||
| EPS (TTM) (₹) | -28.05 | ||
| Beta | 0.1287 | ||
| 3-Year Sharpe Ratio | -0.67 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 72.79 | ||
| 14-Day RSI | 38.84 | ||
| 14-Day ATR (₹) | 1.332861 | ||
| 20-Day SMA (₹) | 28.89 | ||
| 12-1 Month Momentum % | -66.16 | ||
| 52-Week Range (₹) | 22.8 - 95 | ||
| Shares Outstanding (Mil) | 15.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mangalam Drugs & Organics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mangalam Drugs & Organics Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mangalam Drugs & Organics Ltd Frequently Asked Questions
What is Mangalam Drugs & Organics Ltd(NSE:MANGALAM)'s stock price today?
The current price of NSE:MANGALAM is ₹28.09. The 52 week high of NSE:MANGALAM is ₹95.00 and 52 week low is ₹22.80.
When is next earnings date of Mangalam Drugs & Organics Ltd(NSE:MANGALAM)?
The next earnings date of Mangalam Drugs & Organics Ltd(NSE:MANGALAM) is .
Does Mangalam Drugs & Organics Ltd(NSE:MANGALAM) pay dividends? If so, how much?
Mangalam Drugs & Organics Ltd(NSE:MANGALAM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mangalam Drugs & Organics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers